Straumann Holding AG (WBO:STMN) FFO


WBO:STMN Straumann Holding AG WBO:STMN
76 GF Score
Price €116.00
GF Value €149.34
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Straumann Holding AG FFO?

FFO (Funds from operations) only applies to REITs.

WBO:STMN
76GF Score
Straumann Holding AG WBO:STMN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Straumann Holding AG (WBO:STMN) Overvalued in 2026?

Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued. The current stock price of €116.00 is trading 22.3% below its estimated GF Value™ of €149.34. GuruFocus considers Straumann Holding AG to be Modestly Undervalued.

Key valuation signals for WBO:STMN:

  • FFO:
  • GF Value™: €149.34 vs. price of €116.00 (22.3% below fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the WBO:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Straumann Holding AG Business Description

Address Peter Merian-Weg 12, Basel, CHE, 4002
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
76GF Score

Get the complete analysis for WBO:STMN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€116.00
Price
€149.34
GF Value